Health Legislation

The Decree sets out the statutes of the Nigerian Pharmaceutical Regulatory Agency.

The Decree adopts the national pharmaceutical policy. This policy sets out and prioritizes the medium- and long-term goals set by the State for the pharmaceutical sector, and defines the main strategies for achieving them. It provides a framework within which pharmaceutical sector activities are coordinated. It covers both the public and private sectors, and involves all the main players in the pharmaceutical sector. It is an integral part of national health policy.

The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.

The decree revises Niger's national list of essential medicines.

The purpose of the law is to determine the fundamental principles of the control of HIV and AIDS in Niger.

The decree creates a multi-sectoral committee to combat counterfeiting and the illicit sale of medicines and other pharmaceutical products, reporting to Niger's Minister of Public Health.

The decree establishes a Committee of Experts in charge of technical evaluation, whose mission is to carry out the technical evaluation of applications for registration of pharmaceutical products for human use. It also gives an opinion on the quality, safety and efficacy of pharmaceutical products for human use submitted for registration.

The decree creates the Commission Nationale du Médicament (CNM) for human use, whose mission is to validate the work of the Expert Committee responsible for the technical evaluation of applications for marketing authorization for pharmaceutical products for human use. It also gives a final opinion on marketing authorization applications; applications for renewal, extension of variation and transfer of marketing authorization; temporary suspension of marketing authorization; and proposals for definitive withdrawal of marketing authorization.

The decree revises Niger's national list of essential medicines from 2009

The law creates a public administrative establishment, with legal personality and financial autonomy, called the Centre national de lutte contre le cancer (National Cancer Center).

The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.

This decree defines the scope of the prohibition on smoking in public places or places open to the public, and specifies the powers of health police officers in enforcing the law on tobacco control. It also sets out the rules governing the liability of manufacturers and distributors of tobacco products in the event of damage caused by the consumption of these products.

This law institutes free treatment of gynaecological cancers by public health establishments for the benefit of women.

The purpose of this Act is to: a) protect the health of the population against the many debilitating and fatal diseases caused by tobacco; b) limit the population's access to tobacco and protect it from inducements to use tobacco and the smoking which may result; c) make the population aware of the dangers of tobacco use and exposure to tobacco smoke.

This law governs reproductive health in Niger. It sets out the principles of reproductive health, and regulates reproductive health structures, care and services, among other aspects.

The decree sets out the application of decree no. 205-316/PRN/MSP/LCE of November 11, 2005, granting women free caesarean section services provided by public health establishments.

This decree grants women free access to caesarean section services provided by public health establishments.

The Ordinance provides legislation governing pharmacy. The ordinance regulates the classification of medicines, the registration of medicines, the dispensing of medicines, dietary products, cosmetics, the rules for practicing the profession of pharmacist, the dispensing of medicines by doctors and other aspects.